Full of much of the same exact content as the old one if you look close enough ... a new font or pics won't change the fact that Starpharma still haven't delivered on their long touted DEP® license deal but I did get a laugh when I read these pages :
Not one of the supposed current partnerships is mentioned by name on this page - shouldn't this be where Starpharma promote the partners ? ...... and of course it features this same old statement from the old website -
Licensing options are available for Starpharma's clinical candidates. You can click here to learn more about our internal DEP® pipeline.
If you are interested in discussing access to the DEP® technology through partnerships, collaborations, or licensing, please contact Starpharma's Business Development team at [email protected].
Fancy dedicating an entire webpage to DEP® docetaxel after declaring this in the Business Update and subsequently the Webinar earlier in the year ?
"In an effort to clearly prioritise the most commercially significant opportunities with DEP® irinotecan and DEP® cabazitaxel, we have decided to pause active business development outreach for DEP® docetaxel"
